98%
921
2 minutes
20
Nonhomologous end-joining (NHEJ)1 deficiency causes a genome maintenance disorder (GMD), classically associated with severe combined immunodeficiency. Here, we describe two cases of NHEJ1 deficiency presenting with cytopenias. One patient was an adolescent with recurrent cytopenias and frank immunodeficiency that evolved into bone marrow failure with myelodysplasia, then chronic myelomonocytic leukemia and ultimately treatment-refractory acute myeloid leukemia. The second patient was a preadolescent with only cytopenias. In both cases, diagnosis was not achieved by sending an inherited BMF syndrome panel because of the omission of NHEJ1. Our cases further emphasize that NHEJ1 deficiency harbors additionally under-recognized hematopoietic implications beyond lymphoid abnormalities, adding to the emerging evidence for coexistent myeloid and lymphoid concerns in GMDs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/pbc.31884 | DOI Listing |
Mol Cell
July 2025
State Key Laboratory of Cardiology and Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China; Cancer Center, Tongji University School of Medicine, Shanghai 200331, China. Electronic address:
Metabolic reprogramming and DNA damage repair are essential in tumorigenesis and chemoresistance, yet their link remains elusive. Here, we show that LDHA deficiency impairs NHEJ and class switch recombination. Additionally, glycolysis-derived lactate promotes XLF lactylation at K288 within its Ku-binding motif (X-KBM) to regulate NHEJ.
View Article and Find Full Text PDFPediatr Blood Cancer
September 2025
Department of Genetic Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Nonhomologous end-joining (NHEJ)1 deficiency causes a genome maintenance disorder (GMD), classically associated with severe combined immunodeficiency. Here, we describe two cases of NHEJ1 deficiency presenting with cytopenias. One patient was an adolescent with recurrent cytopenias and frank immunodeficiency that evolved into bone marrow failure with myelodysplasia, then chronic myelomonocytic leukemia and ultimately treatment-refractory acute myeloid leukemia.
View Article and Find Full Text PDFAnn Hematol
March 2025
Department of Clinical and Chemical Pathology, Faculty of Medicine, Sohag University, Sohag, 82524, Egypt.
This study investigates the burden, phenotypes, progression, and outcomes of familial hematological malignancies (FHM) through clinical evaluation, gene panel testing, and whole exome sequencing, highlighting the significance of identifying genetic causes for personalized treatment. Over six years, 357 patients initially diagnosed with bone marrow failure (BMF) were evaluated, with 152 patients lacking identifiable causes undergoing further analysis. Among these, 53 (34.
View Article and Find Full Text PDFBiomedica
December 2024
Servicio de Inmunología y Alergología, Fundación Universitaria Ciencias de la Salud - FUCS, Bogotá, D. C., Colombia.
Cernunnos/XLF deficiency is a rare, severe combined immunodeficiency, inherited in an autosomal recessive pattern (OMIM number: 611290), related to the NHEJ1 gene. This gene participates in the DNA non-homologous end-joining pathway, repairing double-strand breaks in the DNA of mammalian cells. The clinical features include growth retardation, microcephaly, triangle-shaped face, recurrent infections, fibroblast's excessive sensitivity to gamma-ionizing radiation, and hypogammaglobulinemia; also, low counts of subpopulations of B and T lymphocytes, with normal values of natural-killer cells.
View Article and Find Full Text PDFEur J Med Genet
October 2023
Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.
Cernunnos deficiency is a rare genetic disorder characterized by immunodeficiency, microcephaly, growth retardation, bird-like facies, sensitivity to ionizing radiation, few autoimmune manifestations, premature aging of hematopoietic stem cells at an early age, and occasional myeloproliferative disease. Herein we present five Egyptian Cernunnos patients from 3 different families. We describe the patients' clinical phenotypes, their immunological profile as well as genetic results.
View Article and Find Full Text PDF